S100A7/psoriasin, a protein belonging to the S100A family of Ca2+ binding proteins, is known to exhibit an antimicrobial activity but it has also been implicated in the regulation of cell proliferation, differentiation, invasion and metastasis. By using a proteomic approach, S100A7/psoriasin has been recently identified in the whole saliva of patients with Systemic Sclerosis as a potential disease biomarker. The aim of the present study were : 1) to compare the expression of salivary S100A7/psoriasin in patients with Sjogren's Syndrome associated to anti-centromere antibodies (ACA) positive Systemic Sclerosis (SS-SSc) versus patients with primary Sjogren's Syndrome (pSS) and 2) to explore any correlation between salivary S100A7/psoriasin and oral damage. S100A7/psoriasin levels were significantly higher in SS-SSc subjects; S100A7/psoriasin salivary levels negatively correlated with the unstimulated salivary flow (USF) rate; The salivary expression of the protein was significantly associated with the Sjogren's Syndrome disease damage index and specifically with the complete loss of teeth. In conclusion, salivary S100A7/psoriasin might be useful in differentiating pSS from SS-SSc and seems to be able to reflect oral damage in both pSS and SS overlapping disorders.

Salivary Expression of S100A7/Psoriasin and Oral Damage in Primary Sjögren's Syndrome and Overlapping Disorders.

SERNISSI, FRANCESCA;BALDINI, CHIARA;MARTINI, DANIELA;LORENZINI, LEONARDO;SABBATINI, ANTONIETTA RAFFAELLA MARIA;GIACOMELLI, CAMILLO;BOMBARDIERI, STEFANO
2014-01-01

Abstract

S100A7/psoriasin, a protein belonging to the S100A family of Ca2+ binding proteins, is known to exhibit an antimicrobial activity but it has also been implicated in the regulation of cell proliferation, differentiation, invasion and metastasis. By using a proteomic approach, S100A7/psoriasin has been recently identified in the whole saliva of patients with Systemic Sclerosis as a potential disease biomarker. The aim of the present study were : 1) to compare the expression of salivary S100A7/psoriasin in patients with Sjogren's Syndrome associated to anti-centromere antibodies (ACA) positive Systemic Sclerosis (SS-SSc) versus patients with primary Sjogren's Syndrome (pSS) and 2) to explore any correlation between salivary S100A7/psoriasin and oral damage. S100A7/psoriasin levels were significantly higher in SS-SSc subjects; S100A7/psoriasin salivary levels negatively correlated with the unstimulated salivary flow (USF) rate; The salivary expression of the protein was significantly associated with the Sjogren's Syndrome disease damage index and specifically with the complete loss of teeth. In conclusion, salivary S100A7/psoriasin might be useful in differentiating pSS from SS-SSc and seems to be able to reflect oral damage in both pSS and SS overlapping disorders.
File in questo prodotto:
File Dimensione Formato  
Sabbatini_789752.pdf

accesso aperto

Tipologia: Versione finale editoriale
Licenza: Creative commons
Dimensione 44.44 kB
Formato Adobe PDF
44.44 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/789752
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact